These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83. Antibiotic cost savings from formulary restrictions and physician monitoring in a medical-school-affiliated hospital. Woodward RS; Medoff G; Smith MD; Gray JL Am J Med; 1987 Nov; 83(5):817-23. PubMed ID: 3674089 [TBL] [Abstract][Full Text] [Related]
84. Developing drug-use profiles from drug-charge records. Hlynka JN; Smith WE; Brodie DC Am J Hosp Pharm; 1979 Oct; 36(10):1347-51. PubMed ID: 507077 [TBL] [Abstract][Full Text] [Related]
85. Drug cost containment at a large teaching hospital. Pillans PI; Conry I; Gie BE Pharmacoeconomics; 1992 May; 1(5):377-82. PubMed ID: 10147002 [TBL] [Abstract][Full Text] [Related]
86. Comparison of absorption and excretion of cefazolin with cephalothin and cephapirin. Shimizu T Jpn J Antibiot; 1975 Aug; 28(4):542-8. PubMed ID: 1160145 [TBL] [Abstract][Full Text] [Related]
87. A survey of cephalosporin use. Monitoring use in a hospital setting. Arthurson SL; Turnidge JD; Odgers CL Med J Aust; 1979 Oct; 2(8):436-9. PubMed ID: 318492 [TBL] [Abstract][Full Text] [Related]
88. Drug product selection by formulary committees in Sweden. Lilja J Am J Hosp Pharm; 1979 Aug; 36(8):1042, 1044. PubMed ID: 484560 [No Abstract] [Full Text] [Related]
89. Effect of control programs on cefazolin prescribing in a teaching hospital. Ma MY; Goldstein EJ; Meyer RD Am J Hosp Pharm; 1979 Aug; 36(8):1055-8. PubMed ID: 484564 [No Abstract] [Full Text] [Related]
91. Formulary management as a tool to improve medication use and gain physician support. Lehmann DF; Guharoy R; Page N; Hirschman K; Ploutz-Snyder R; Medicis J Am J Health Syst Pharm; 2007 Mar; 64(5):464-6. PubMed ID: 17322158 [No Abstract] [Full Text] [Related]
92. Developing a successful strategy for controlling inappropriate antibiotic use and cost. Mu-Chow KJ; Rich DS Top Hosp Pharm Manage; 1988 Aug; 8(2):1-21. PubMed ID: 10314291 [No Abstract] [Full Text] [Related]
93. Antimicrobial surveillance in a VAMC teaching hospital--resulting cost avoidance. Powers DA Drug Intell Clin Pharm; 1986 Oct; 20(10):803-5. PubMed ID: 3533488 [TBL] [Abstract][Full Text] [Related]
94. Is there cost reduction potential for extended half-life cephalosporins? Scalley RD; Stuart CC Drug Intell Clin Pharm; 1986 Dec; 20(12):975-80. PubMed ID: 3816548 [TBL] [Abstract][Full Text] [Related]
95. Selection of cephalosporins for hospital formularies. Wilson WR Diagn Microbiol Infect Dis; 1995; 22(1-2):129-34. PubMed ID: 7587026 [TBL] [Abstract][Full Text] [Related]
96. Reduction in antibiotic costs by restricting use of an oral cephalosporin. Seligman SJ Am J Med; 1981 Dec; 71(6):941-4. PubMed ID: 7315856 [TBL] [Abstract][Full Text] [Related]
97. Formulary conversion of cefoxitin usage to cefotetan: experience at a large teaching hospital. Smith KS; Briceland LL; Nightingale CH; Quintiliani R DICP; 1989 Dec; 23(12):1024-30. PubMed ID: 2603441 [TBL] [Abstract][Full Text] [Related]
98. Influence of cephalosporin antibiotics on blood coagulation and platelet function. Natelson EA; Brown CH; Bradshaw MW; Alfrey CP; Williams TW Antimicrob Agents Chemother; 1976 Jan; 9(1):91-3. PubMed ID: 1259395 [TBL] [Abstract][Full Text] [Related]